ATGL vs AZ

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability. Despite a strong gross margin of 54.06% and a healthy current ratio of 4.18, the company is unprofitable with deeply negative operating and net margins, collapsing revenue growth of -49.30% YoY, and extremely elevated valuation multiples. The absence of Altman Z-Score and key valuation metrics like Graham Number further underscores data limitations and financial opacity. Recent price performance shows a sharp reversal from long-term gains, with significant declines over the past 6 months and 1 month, suggesting deteriorating market confidence.

The company exhibits extremely weak financial health with a Piotroski F-Score of just 1/9, indicating severe operational and profitability concerns. Despite strong short-term earnings surprises and a bullish analyst target price of $30.00, the firm remains deeply unprofitable with negative operating margins (-265.87%), negative ROE (-89.37%), and declining year-over-year revenue (-1.60%). High valuation multiples, including a Price/Sales ratio of 41.74, suggest the stock is pricing in aggressive future growth not supported by current fundamentals. While liquidity ratios are strong and debt is minimal, the lack of profitability and inconsistent earnings trajectory raise material sustainability concerns.